Publications by authors named "Baitian Zhao"
Article Synopsis
- * The treatment showed a 37.5% objective response rate and an 85.0% disease control rate, with a median progression-free survival of 9.5 months and a 1-year overall survival rate of 73.3%.
- * Common severe side effects included hand-foot syndrome (22.5%) and oral mucositis (17.5%), while circulating tumor DNA (ctDNA) analysis indicated its potential as a predictive biomarker for treatment response and disease progression.
Article Synopsis
- * After two doses, nearly half of the patients achieved a complete response, and by the end of treatment, 95.7% showed an objective response, indicating the therapy's high efficacy.
- * The treatment was deemed safe, with only one significant side effect reported, and a 100% overall survival rate among patients during a median follow-up of 21.3 months.